This article is part of the HBOT Radar series, where we summarize the latest published hyperbaric oxygen therapy research.
Disclaimer: This article is intended for educational and informational purposes only. It summarizes published medical research conducted in clinical settings and does not evaluate Brain Spa Hyperbaric products. The hyperbaric chambers offered on this website are non-medical wellness devices and are not intended to diagnose, treat, cure, or prevent any disease. Do not make medical decisions based on this article — consult a qualified healthcare professional.
Title:
New review finds HBOT improves recovery in sudden sensorineural hearing loss — especially when started early and combined with steroids
What this review examined
Sudden sensorineural hearing loss (SSNHL) is a true medical emergency — rapid loss of hearing that can happen within hours or days.
Early treatment is critical, but outcomes vary widely.
This 2025 review summarizes the most recent research on how and when hyperbaric oxygen therapy is used in SSNHL.
What kind of paper this is. This is a narrative review rather than a meta-analysis. It gathers and interprets the existing literature without pooling the numbers, which means it is good for understanding the state of the field and poor for telling you how large any effect is.
The review focuses on:
- biological mechanisms
- clinical effectiveness
- where evidence is strong vs inconsistent
- gaps in standardized protocols
How HBOT helps sudden hearing loss
HBOT supports several key physiological processes inside the inner ear:
1. Increases oxygen in the cochlea
The inner ear has poor circulation. Raising dissolved oxygen reaches tissue that ordinary breathing struggles to supply, which the review links to hair-cell survival.
2. Improves microcirculation
Better blood flow helps rescue tissue at risk of dying.
3. Reduces inflammation
Inflammation is a major driver of acute hearing damage, and hyperbaric oxygen has documented anti-inflammatory effects. The review treats this as one of the plausible routes to benefit.
How well these mechanisms translate into recovered hearing is what the clinical section below examines.
HBOT protocols discussed
One of the biggest challenges highlighted in the review is the lack of standardization.
Across studies, treatment parameters vary widely:
- different pressure settings
- different session counts
- different treatment windows
- different combinations with medications
Because of this, results across studies can appear inconsistent.
But despite variations, multiple studies show meaningful improvement, especially when HBOT is combined with steroids and started early.
Pressure ranges in the literature generally fall between 1.5–2.5 ATA, though the review emphasizes that the optimal parameters remain undetermined.
What the clinical evidence shows
HBOT + steroids = strongest improvement
Across the studies where hyperbaric oxygen was added to glucocorticoid therapy, the review reports higher hearing recovery rates and better outcomes than medication alone. The review does not pool these results statistically, so this is a described pattern rather than a calculated effect size.
Early intervention matters
The earlier HBOT is started after hearing loss, the better the results.
Not all studies agree
Because of:
- small sample sizes
- lack of standardized protocols
- different timing of treatment
The review attributes much of the variability between studies to differing protocols. That is a reasonable reading, but it is not the only one — inconsistent results can also mean a small or conditional effect, and this review cannot rule that out.
Reported side effects
Across the studies covered, adverse effects were reported as uncommon and usually mild — ear pressure, sinus discomfort.
Why this matters
SSNHL is one of the conditions where time is critical.
Inner ear tissues can deteriorate rapidly, and the therapeutic window is narrow.
This review reinforces:
- the mechanisms hyperbaric oxygen acts on line up with what is thought to damage hearing in SSNHL
- the studies covered report better outcomes when it is added to medication
- the review describes the combination approach as increasingly accepted in ENT practice
- More uniform protocols are urgently needed
Takeaway for the community
The 2025 review concludes that:
- hyperbaric oxygen is described as a useful adjunct in sudden sensorineural hearing loss
- Best outcomes occur when started early and used together with steroids
- HBOT improves oxygen supply, microcirculation and inflammation in the inner ear
- protocols vary widely across studies, which the review sees as a major source of inconsistent results
- reported side effects were uncommon and mild in the studies covered
HBOT Radar continues to track the most up-to-date research on hearing loss and neurological recovery.
Study link: https://pubmed.ncbi.nlm.nih.gov/40910260/
Educational disclaimer
This content summarizes findings from published medical research for educational purposes only.
The hyperbaric chambers sold on this website are non-medical wellness devices and are not intended to diagnose, treat, cure, or prevent any disease.
The studies discussed here were conducted in clinical medical settings using medical-grade interventions. The inclusion of research summaries does not imply that similar outcomes can be achieved using non-medical wellness devices.
